The ameliorating effect of Centella asiatica ethanolic extract on albino rats treated with isoniazid

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 28, Issue 1, 2017, Pages 67-77

  Ghosh, Kavisa ^a   Indra, N ^a   Jagadeesan, G ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

antioxidant; Centella asiatica; haematological; isoniazid; kidney; liver

Indexed keywords

CATALASE; CENTELLA ASIATICA EXTRACT; GLUTATHIONE; ISONIAZID; SILYMARIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; PLANT EXTRACT; TRITERPENE; TUBERCULOSTATIC AGENT;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HISTOLOGY; KIDNEY FUNCTION; LIVER FUNCTION; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PLANT LEAF; RAT; ANIMAL; DRUG EFFECTS; ISOLATION AND PURIFICATION; KIDNEY; LIVER; PATHOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; ANTITUBERCULAR AGENTS; ISONIAZID; KIDNEY; LIVER; MALE; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; TRITERPENES;

EID: 85008474599     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/jbcpp-2016-0059     Document Type: Article

References (51)

1. World Health Organization. Global tuberculosis report 2013. WHO, 2013.
2. Adebayo AJ, Adetokunbo OA, Kehinde AJ, Olamide AE, Oluwatosin A. Microsomal lipid peroxidation, antioxidant enzyme activities in brain of male rats during long-term exposure to isoniazid. J Drug Metab Toxicol 2012;3:127.
3. Zumla A, Nahid P, Cole ST. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 2013;12:388-404.
4. Centers for Disease Control and Prevention, Division of Tuberculosis Elimination (DTBE). Tuberculosis: treatment. Online: http://www.cdc.gov/tb/topic/treatment/default.htm. Accessed: 8 Sep 2014.
5. Mahapatra S, Woolhiser LK, Lenaerts AJ, Johnson JL, Eisenach KD, Joloba ML, et al. A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct. Antimicrob Agents Chemother 2012;56:28-35.
6. Mattioni S, Zamy M, Mechai F, Raynaud JJ, Chabrol A, Aflalo V, et al. Isoniazid-induced recurrent pancreatitis. JOP J Pancreas 2012;13:314-6.
7. Blair IA, Mansilla Tinoco R, Brodie MJ, Clare RA, Dollery CT, Timbrell JA, et al. Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. Hum Toxicol 1985;4:195-202.
8. MMWR. Centers for Disease Control and Prevention. Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection-United States, 2004-2008. Morb Mortal Wkly Rep 2010;59:224-9.
9. Luntz GR, Smith SG. Effect of isoniazid on carbohydrate metabolism in controls and diabetics. Br Med J 1953;1: 296-9.
10. Mukherjee S, Dugad S, Bhandare R, Pawar N, Jagtap S, Pawar PK, et al. Evaluation of comparative free-radical quenching potential of Brahmi (Bacopa monnieri) and Mandookparni (Centella asiatica). Ayu 2011;32:258-64.
11. Gohil KJ, Patel JA, and Gajjar AK. Pharmacological review on Centella asiatica: a potential herbal cure-all. Indian J Pharm Sci 2010;72:546-56.
12. Meena H, Pandey HK, Pandey P, Arya MC, Ahmed Z. Evaluation of antioxidant activity of two important memory enhancing medicinal plants Baccopa monnieri and Centella asiatica. Indian J Pharmacol 2012;44:114-7.
13. Yu QL, Duan HQ, Takaishi Y, Gao WY. A novel triterpene from Centella asiatica. Molecules 2006;11:661-5.
14. Seevaratnam V, Banumathi P, Premalatha MR, Sundaram SP, Arumugam T. Functional properties of Centella asiatica (L.): a review. Int J Pharm Pharm Sci 2012;4:8-14.
15. Ghosh K, Indra N. Phytochemistry, in vitro free radical scavenging, chelating and toxicity of Centela asiatica L. (Apiaceae) ethanolic leaf extract. Int J Pharm Sci Rev Res 2014;29:328-34.
16. Santhosh S, Sini TK, Anandan R, Mathew PT. Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats. Eur J Pharmacol 2007;572:69-73.
17. Rana SV, Pal R, Vaiphei K, Ola RP, Singh K. Hepatoprotection by carotenoids in isoniazid-rifampicin induced hepatic injury in rats. Biochem Cell Biol NBC Res 2010;88:819-34.
18. Sasaki T, Matsy S, Sonae A. Effect of acetic acid concentration on the color reaction in the O-toluidine boric acid method for blood glucose estimation. Rinsho Kagak 1972;1:346-53.
19. Dacie JV, Lewis SN. Practical haematology, 6th ed. Edinburg: Churchill Livingstone, 1984.
20. Hogberg J, Larson RE, Kristoferson A, Orrenius S. NADPHdependent reductase solubilised from microsomes of peroxidation and its activity. Biochem Biophys Res Commun 1974;56:836-42.
21. Kakkar R, Mantha SV, Prasad RK, Kalra J. Increased oxidative stress in rat liver and pancrease during progression of streptozotocin induced diabetes. Clin Sci 1998;94:69-74.
22. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972;47:389-94.
23. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione-s-transferase activities in rat lung and liver. Biochem Biophys Acta 1979;582:67-78.
24. Lowry OH, Rosebrough NJ, Farn AL, Randall RJ. Protein measurement with the folic phenol reagent. J Biol Chem 1951;193:265-75.
25. Doumas BT, Watson WA, Biggs HC. Albumin standards and management of serum albumin with bromocresol green. Clin Chim Acta 1971;31:87-96.
26. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28:56-63.
27. King EJ, Armstrong AR. A convenient method for determining of serum and bile phosphatase activity. J Can Med Assoc 1934;31:376-81.
28. Malloy E, Evelyn K. The determination of bilirubin with the photoelectric colorimeter. J Biol Chem 1937;119:481-5.
29. Patton CJ, Crouch SR. Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia. Anal Chem 1977;49:464-9.
30. Antony B, Santhakumari G, Merina B, Sheeba V, Mukkadan J. Hepatoprotective effect of Centella asiatica (L) in carbon tetrachloride-induced liver injury in rats. Indian J Pharmaceut Sci 2006;68:772-6.
31. Abdulla MA, Al-Bayaty FH, Younis LT, Abu Hassan MI. Anti-ulcer activity of Centella asiatica leaf extract against ethanol-induced gastric mucosal injury in rats. J Med Plants Res 2010;4:1253-9.
32. Pradhan SC, Girish C. Hepatoprotective herbal drug, SIL from experimental pharmacology to clinical medicine. Indian J Med Res 2006;124:491-504.
33. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Safety 1996;14:406-23.
34. Pandey AS, Surana A. Isoniazid-induced recurrent acute pancreatitis. Trop Doct 2011;41:249-50.
35. Tousif S, Singh DK, Ahmad S, Moodley P, Bhattacharyya M, Van Kaer L, et al. Isoniazid induces apoptosis of activated CD4+ T cells: implications for post-therapy tuberculosis reactivation and reinfection. J Biol Chem 2014;289:30190-5.
36. Comstock GW, Baum C, Snider DE Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis 1979;119:827-30.
37. Yilmaz HR, Uz E, Gökalp O, Ozçelik N, Ciçek E, Ozer MK. Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats. Toxicol Ind Health 2008;24:519-24.
38. Huang SC, Benz EJ. Chapter 8: posttranscriptional factors influencing the hemoglobin content of the red cell. In: Steinberg MH, Higgs D, Nagel RL, editors. Disorders of hemoglobin: genetics, pathophysiology, and clinical management. Cambridge, UK: Cambridge University Press, 2001:146-73.
39. Hutchison RE, McPherson RA, Schexneider KI. Chapter 30: basic examination of blood and bone marrow. In: McPherson RA, Pincus MR, editors. Henry's clinical diagnosis and management by laboratory methods, 22nd ed. Philadelphia, PA: Elsevier Saunders, 2011.
40. Singh A, Bhat TK, Sharma OP. Clinical biochemistry of hepatotoxicity. J Clinic Toxicol 2011;S4:001. doi:10.4172/2161-0495. S4-001.
41. Hussain SM, Frazier JM. Cellular toxicity of hydrazine in primary rat hepatocytes Toxicol Sci 2002;69:424-32.
42. Attri S, Rana SV, Vaiphei K, Sodhi CP, Katyal R, Goel RC, et al. Isoniazid and rifampicin induced oxidative hepatic injury protection by N-acetylcysteine. Hum Exp Toxicol 2000;19: 517-22.
43. Lei XG, Cheng WH, McClung JP. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr 2007; 27:41-61.
44. Rao RR. Mechanism of drug induced hepatotoxicity. Ind J Pharmacol 1973;5:313-8.
45. Jaydeokar AV, Bandawane DD, Bibave KH, Patil TV. Hepatoprotective potential of Cassia auriculata roots on ethanol and antitubercular drug-induced hepatotoxicity in experimental models. Pharm Biol. 2014;52(3):344-55.
46. Thapa BR, Walia A. Liver function tests and their interpretation. Indian J Pediatr 2007;74:663-71.
47. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, and Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003;167:1472-7.
48. Sharmila R, Sindhu G, Arockianathan PM. Nephroprotective effect of β-sitosterol on N-diethylnitrosamine initiated and ferric nitrilotriacetate promoted acute nephrotoxicity in Wistar rats. J Basic Clin Physiol Pharmacol 2016;27:473-82.
49. Jadhav R, Mateenuddin M. Effect of Nigella sativa oil on hepatotoxicity induced by antitubercular drugs in albino rats. Indian Med Gazette 2013;147:145-51.
50. Sankar M, Rajkumar J, Sridhar D. Hepatoprotective activity of heptoplus on isoniazid and rifampicin induced liver damage in rats. Indian J Pharm Sci 2015;77:556-62.
51. Hussein OE, Germoush MO, Mahmoud AM. Ruta graveolens protects against isoniazid/rifampicin-induced nephrotoxicity through modulation of oxidative stress and inflammation. Glob J Biotechnol Biomater Sci 2016;1:008-13.